“From 2019 to 2024, the percentage of adult patients with a diagnosis of overweight or obesity increased 50.7 percent, and ...

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...

Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...

The Hunting Wives' actress Chrissy Metz gets candid in a new cover story for PEOPLE on her thoughts about using weight loss ...

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...

Scientists have uncovered a way to promote weight loss and improve blood sugar control without the unpleasant side effects of ...

Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...

The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern ...

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.